Vanessa N Olsen, MD
Obstetrics/Gynecology · Richmond
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Olsen’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A103727 · Current
Licensed to practise in California · since 2008 · expires 2027-11-30 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$10,054
Pharmacies billed $10,054 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
158 generic and 11 brand-name prescriptions · $10,054 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 45 | $2,826 | $46 |
| Betamethasone Diprop Augmented | 12 | $571 | $34 |
Year by year
| 2024 | 169 | 74 | None | 7% | $10,054 |
| 2023 | 134 | 57 | 0% (0) | 13% | $14,028 |
| 2022 | 138 | 53 | None | 16% | $14,357 |
| 2021 | 121 | 52 | None | 20% | $14,143 |
| 2020 | 101 | 42 | None | 17% | $10,398 |
| 2019 | 99 | 57 | None | None | $7,163 |
| 2018 | 92 | 42 | None | 16% | $11,218 |
| 2017 | 75 | 38 | None | 27% | $13,444 |
| 2016 | 92 | 41 | None | 32% | $11,245 |
| 2015 | 90 | 43 | None | 29% | $11,007 |
| 2014 | 79 | 34 | None | 42% | $7,535 |
| 2013 | 64 | 29 | None | 44% | $7,534 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Estring | 12 | $7,133 | $594 |
| Estradiol | 51 | $2,350 | $46 |
| Betamethasone Diprop Augmented | 18 | $583 | $32 |
2022: 3 drugs
| Estring | 14 | $7,937 | $567 |
| Estradiol | 47 | $2,480 | $53 |
| Trospium Chloride | 11 | $511 | $46 |
2021: 3 drugs
| Estring | 15 | $8,248 | $550 |
| Estradiol | 33 | $1,877 | $57 |
| Betamethasone Diprop Augmented | 15 | $722 | $48 |
2020: 3 drugs
| Estring | 11 | $5,840 | $531 |
| Estradiol | 30 | $1,707 | $57 |
| Betamethasone Diprop Augmented | 13 | $566 | $44 |
2019: 3 drugs
| Estrace | 12 | $1,671 | $139 |
| Estradiol | 15 | $662 | $44 |
| Betamethasone Diprop Augmented | 11 | $435 | $40 |
2018: 1 drug
| Estrace | 40 | $5,386 | $135 |
2017: 2 drugs
| Estrace | 22 | $6,980 | $317 |
| Oxybutynin Chloride Er | 13 | $927 | $71 |
2016: 2 drugs
| Estrace | 14 | $3,996 | $285 |
| Premarin | 12 | $3,118 | $260 |
2015: 1 drug
| Premarin | 15 | $3,569 | $238 |
2014: 2 drugs
| Premarin | 22 | $3,903 | $177 |
| Fluconazole | 11 | $80 | $7 |
2013: 1 drug
| Premarin | 17 | $2,505 | $147 |
Professional record
- NPI
- 1265680748
- Licence
- CA A103727California A103727: Current · expires 2027-11-30
- Trained
- University of California, San Francisco School of Medicine, 2006
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 710 Lawrence Expy, Womens Clinic, Santa Clara, CA, 95051
- NPI first listed
- 2008-09-09
- NPI last updated
- 2022-01-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.